Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: The Third National Health and Nutrition Examination Survey

Journal of the National Medical Association

Volumn 96, Issue 11, 2004, Pages 1470-1476

  Gillum, Richard F ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Coronary disease; Diabetes mellitus; Glucose tolerance; Health surveys; Helicobacter pylori; Insulin; Obesity; Serum

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

AGE; BACTERIAL INFECTION; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ETHNOLOGY; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 8344235956     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Dore MP, Bilotta M, Malaty HM, et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition. 2000;16:407-410.
2. de Luis DA, Lahera M, Canton R, et al. Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care. 1998;21:1129-1132.
3. Ekesbo R, Nilsson PM, Lindholm LH, et al. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity, and social factors. J Cardiovasc Risk. 2000;7:191-195.
4. Perdichizzi G, Bottari M, Pallio S, et al. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and diabetic subjects. New Microbiol. 1996;19:149-154.
5. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Br Med J. 1998;316:130-132.
6. Strachan DP, Mendall MA, Carrington D, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation. 1998;98:1286-1290.
7. Ridker PM, Danesh J, Youngman L, et al. A prospective study of seropositivity for H. pylori and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann Intern Med. 2001;135:184-188.
8. Heuschmann PU, Neureiter D, Gesslein M, et al. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke. 2001;32:2253-2258.
9. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15-21.
10. Haffner SM. Progress in population analyses of the insulin resistance syndrome. Ann NY Acad Sci. 1997;827:1-12.
11. Fagan TC, Deedwania PC. The cardiovascular dysmetabolic syndrome. Am J Med. 1998;105:77S-82S.
12. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiologic Reviews. 1998;20:157-172.
13. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 1996;334:374-381.
14. Anderson RA. Contributing factors to insulin resistance. Role of dietary factors: micronutrients. Nutr Reviews. 2000:58(II):S10-S11.
15. Hanefeld M. The metabolic syndrome: roots, myths, and facts. In: Hanefeld M, Leonhardt W, eds. The metabolic syndrome. Jena, Gustav Fischer. 1997:13-24.
16. Lempiainen P, Mykkanen L, Pyorala K, et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation. 1999;100:123-128.
17. Flier JS. An overview of insulin resistance. In: Moller DE ed. Insulin resistance. Chichester, John Wiley & Sons, 1993:1-8.
18. Stout RW. Insulin resistance, hyperinsulinemia, dyslipidemia, and atherosclerosis. In: Moller DE, ed. Insulin resistance. Chichester, John Wiley & Sons, 1993:355-384.
19. Janka HU. Metabolic syndrome and type-II diabetes. In: Hanefeld M, Leonhardt W eds. The metabolic syndrome. Jena, Gustav Fischer. 1997:62-69.
20. Reaven GM. The pathophysiological consequences of adipose tissue insulin resistance. In: Reaven GM, Laws A, eds. Insulin resistance: the metabolic syndrome X. Totowa, NJ, Human Press, 1999:233-246.
21. Laws A. Insulin resistance and dyslipidemia: implications for coronary heart disease risk. In: Reaven GM, Laws A, eds. Insulin resistance: the metabolic syndrome X. Totowa, NJ, Human Press, 1999:267-280.
22. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. National Center for Health Statistics. Vital Health Stat. 1(32), 1994.27.
23. Vargas CM, Burt Vicki L, Gillum RF. Cardiovascular disease in the NHANES III. Ann Epidemiology. 1997;7:523-525.
24. Gunter EW, Lewis BG, Koncikowski SM. Laboratory procedures use for the Third National Health and Nutrition Examination Survey, 1988-1994 [CD ROM]. National Center for Health Statistics, 1996.
25. Harris MI, Klegal KM, Cowie CC, et al. Prevalence of diabetes, impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
26. Harris MI, Eastman RC, Cowie CC, et al. Racial and ethnic differences in glycemic control of adults with type-2 diabetes. Diabetes Care. 1999;22:403-408.
27. Westat Inc. National Health and Nutrition Examination Survey III. Body Measurements (Anthropometry). National Center for Health Statistics, 1996.
28. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22:39-47.
29. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infecf Dis. 2000;181:1359-1363.
30. Staat MAA, Kruszon-Moran, McQuillan GM, et al. A population-based serologic survey of Heilcobacter pylori infection in children and adolescents in the United States. J Infect Dis. 1996;174:1120-1123.
31. Mohadjer L, Bell B, Waksberg J. National Health and Nutrition Examination Survey III. Accounting for item nonresponse bias. Rockville, MD, WESTAT, Inc., 1996.
32. SAS Institute Inc. SAS Procedures Guide: statistics, version 6 ed. Cary NC: SAS Institute Inc., 1990;212-55839.
33. National Center for Health Statistics, Landis JR, Lepkowski JM, et al. A statistical methodology for analyzing data from a complex survey, the First National Health and Nutrition Examination Survey. Vital and Health Statistics. Series 2, No. 92. DHHS Pub. No. (PHS) 82-1366. Public Health Service. Washington. U.S. Government Printing Office, Sept. 1982.
34. Shah BV, Barnwell BG, Bieler GS. SUDAAN Software for the Statistical Analysis of Correlated Data User's Manual Release 7.0. Research Triangle Park, NC: Research Triangle Institute, 1996.
35. Best LM, Veldhuyzen van Zanten SJO, et al. Serological detection of Helicobacter pylori antibodies in children and their parents. J Clin Microbiol. 1994;32:1193-1196.
36. Mitchell HM. The epidemiology of Helicobacter pylori. In: Westblom TU, Czinn SJ, Nedrud JG, eds. Gastroduodenal Disease and Helicobacter pylori: pathophysiology, diagnosis, and treatment. Berlin, Springer, 1999:11-30.
37. Blanchard TG, Czinn SSJ, Nedrud JG. Host response and vaccine development to Helicobacter pylori infection. In: Westblom TU, Czinn SJ, Nedrud JG, eds. Gastroduodenal Disease and Helicobacter pylori: pathophysiology, diagnosis, and treatment. Berlin, Springer, 1999:181-213.
38. Parsonnet J. Factors associated with disappearance of Helicobacter pylori in the West. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure 2000. Dordrecht, Kluwer Academic Publishers, 2000:45-52.
39. Malfertheiner P, Leodolter A, Gerards C. Pitfalls in Helicobacter pylori diagnosis. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure 2000. Dordrecht, Kluwer Academic Publishers, 2000:123-138.
40. Czinn SJ, Eisenberg JC, Nedrud and Blanchard TG. Immuno-inflammatory response to Helicobacter pylori in children. In: Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure 2000. Dordrecht, Kluwer Academic Publishers, 2000:169-174.
41. Brenner H, Berg G, Frohlich M, et al. Chronic infection with Helicobacter pylori does not provoke major systemic inflammation in healthy adults: results from a large population-based study. Atherosclerosis. 1999;147:399-403.
42. Ridker PM. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation. 2002;105:2-4.
43. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
44. Sempos CT, Looker AC, Gillum RE, et al. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol. 2000;10:441-448.
45. Meriden T. Progress with thiazolidinediones in the management of type-2 diabetes mellitus. Clin Ther. 2004;26:177-190.